A lawyer for Ratko Mladic says the former Bosnian Serb army chief will spend two days in hospital after suddenly falling ill during his trial at the Yugoslav war crimes tribunal.
Branko Lukic said Mladic feels better than when he collapsed in the courtroom and is able to communicate.
Lukic also said Mladic had regained movement in his right arm and leg after suffering paralysis earlier in the day.
Mladic is on trial for genocide, war crimes, and crimes against humanity for his role in Bosnia's 1992-95 war.
The first witnesses began testifying this week against the former general, who has denied any wrongdoing.
Mladic, 70, has previously complained of health problems and some reports suggest he suffered two strokes during his years in hiding.
He was captured last year after 16 years as an indicted fugitive.
Bosnians and other mourners this week marked the 17th anniversary of the Srebrenica massacre -- a mass killing by Bosnian Serb forces under Mladic's command in 1995 -- by burying 520 more of the more than 8,000 victims of what is regarded as the worst atrocity on European soil since World War II.
Branko Lukic said Mladic feels better than when he collapsed in the courtroom and is able to communicate.
Lukic also said Mladic had regained movement in his right arm and leg after suffering paralysis earlier in the day.
Mladic is on trial for genocide, war crimes, and crimes against humanity for his role in Bosnia's 1992-95 war.
The first witnesses began testifying this week against the former general, who has denied any wrongdoing.
Mladic, 70, has previously complained of health problems and some reports suggest he suffered two strokes during his years in hiding.
He was captured last year after 16 years as an indicted fugitive.
Bosnians and other mourners this week marked the 17th anniversary of the Srebrenica massacre -- a mass killing by Bosnian Serb forces under Mladic's command in 1995 -- by burying 520 more of the more than 8,000 victims of what is regarded as the worst atrocity on European soil since World War II.